Anchor Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$631K Sell
8,065
-1,089
-12% -$87.8K 0.02% 193
2026
Q1
$793K Sell
9,154
-344
-4% -$33K 0.02% 175
2025
Q4
$912K Sell
9,498
-586
-6% -$56.9K 0.03% 178
2025
Q3
$960K Hold
10,084
0.03% 178
2025
Q2
$879K Sell
10,084
-615
-6% -$52.2K 0.03% 185
2025
Q1
$961K Sell
10,699
-1,132
-10% -$101K 0.03% 174
2024
Q4
$945K Sell
11,831
-869
-7% -$75.2K 0.03% 184
2024
Q3
$1.14M Sell
12,700
-40
-0.3% -$3.37K 0.03% 174
2024
Q2
$1M Hold
12,740
0.03% 175
2024
Q1
$1.11M Hold
12,740
0.03% 172
2023
Q4
$1.05M Sell
12,740
-30,858
-71% -$2.35M 0.03% 172
2023
Q3
$3.42M Sell
43,598
-67,341
-61% -$5.64M 0.1% 110
2023
Q2
$9.77M Sell
110,939
-8,093
-7% -$697K 0.25% 101
2023
Q1
$9.6M Sell
119,032
-8,538
-7% -$696K 0.25% 101
2022
Q4
$9.91M Sell
127,570
-96,187
-43% -$7.8M 0.25% 99
2022
Q3
$18.1M Sell
223,757
-12,470
-5% -$1.12M 0.5% 69
2022
Q2
$21.2M Sell
236,227
-9,258
-4% -$938K 0.54% 65
2022
Q1
$27.2M Buy
245,485
+7,633
+3% +$806K 0.58% 63
2021
Q4
$24.6M Sell
237,852
-8,859
-4% -$1.03M 0.49% 76
2021
Q3
$30.9M Buy
246,711
+18,615
+8% +$2.41M 0.64% 60
2021
Q2
$28.3M Buy
228,096
+857
+0.4% +$108K 0.57% 66
2021
Q1
$26.8M Buy
227,239
+15,543
+7% +$1.82M 0.57% 66
2020
Q4
$24.8M Sell
211,696
-2,713
-1% -$299K 0.57% 70
2020
Q3
$22.3M Sell
214,409
-1,433
-0.7% -$144K 0.57% 67
2020
Q2
$19.8M Sell
215,842
-6,873
-3% -$659K 0.51% 76
2020
Q1
$20.1M Sell
222,715
-6,972
-3% -$742K 0.59% 71
2019
Q4
$26.1M Buy
229,687
+17,234
+8% +$1.89M 0.57% 76
2019
Q3
$23.1M Sell
212,453
-7,630
-3% -$796K 0.83% 51
2019
Q2
$21.4M Sell
220,083
-34,900
-14% -$3.19M 0.78% 61
2019
Q1
$23.2M Sell
254,983
-3,486
-1% -$312K 0.49% 54
2018
Q4
$23.5M Buy
258,469
+72
+0% +$6.73K 0.96% 39
2018
Q3
$25.4M Sell
258,397
-8,506
-3% -$786K 0.92% 42
2018
Q2
$22.9M Sell
266,903
-7,433
-3% -$621K 0.84% 49
2018
Q1
$22M Sell
274,336
-1,289
-0.5% -$106K 0.77% 57
2017
Q4
$22.3M Buy
275,625
+6,059
+2% +$485K 0.79% 54
2017
Q3
$21M Sell
269,566
-926
-0.3% -$76.9K 0.76% 60
2017
Q2
$24M Sell
270,492
-4,152
-2% -$350K 0.88% 46
2017
Q1
$22.1M Buy
274,644
+18,820
+7% +$1.47M 0.77% 61
2016
Q4
$18.2M Sell
255,824
-140,437
-35% -$11M 0.69% 67
2016
Q3
$34.2M Sell
396,261
-68,196
-15% -$5.94M 1.15% 31
2016
Q2
$40.3M Sell
464,457
-10,122
-2% -$819K 1.02% 39
2016
Q1
$35.6M Sell
474,579
-13,366
-3% -$1.01M 0.85% 47
2015
Q4
$37.5M Sell
487,945
-20,106
-4% -$1.51M 0.95% 39
2015
Q3
$34M Sell
508,051
-21,514
-4% -$1.58M 0.87% 42
2015
Q2
$39.2M Sell
529,565
-23,943
-4% -$1.83M 0.88% 43
2015
Q1
$43.2M Buy
553,508
+285,067
+106% +$21.6M 0.94% 38
2014
Q4
$19.4M Buy
268,441
+2,560
+1% +$178K 0.39% 86
2014
Q3
$16.5M Sell
265,881
-6,657
-2% -$423K 0.34% 93
2014
Q2
$17.4M Buy
272,538
+1,006
+0.4% +$61.1K 0.33% 92
2014
Q1
$16.7M Buy
271,532
+11
+0% +$641 0.33% 93
2013
Q4
$15.6M Sell
271,521
-559
-0.2% -$31.7K 0.31% 92
2013
Q3
$14.5M Buy
272,080
+4,818
+2% +$259K 0.31% 85
2013
Q2
$13.8M Buy
+267,262
New +$13.2M 0.29% 82

Other funds holding MDT

Anchor Capital Advisors's MDT Position: Q2 2026 in Review

Anchor Capital Advisors reduced its Medtronic (MDT) stake by 12% in Q2 2026, selling an estimated $87.8K and leaving 8,065 shares worth $631K. The position accounts for 0.02% of the portfolio, ranked #193.

Anchor Capital Advisors first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $43.2M in Q1 2015. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Anchor Capital Advisors held 8,065 shares of Medtronic worth $631K as of Q2 2026.
  • Anchor Capital Advisors sold 1,089 Medtronic shares in Q2 2026, an estimated $87.8K.
  • Medtronic made up 0.02% of Anchor Capital Advisors's portfolio in Q2 2026, its #193 holding.
  • Anchor Capital Advisors first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Anchor Capital Advisors's Medtronic position peaked at $43.2M in Q1 2015.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Anchor Capital Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.